Department of Neuroradiology, University Hospital of Nantes, Nantes, France.
Department of Neuroradiology, University Hospital of Rennes, Rennes, France.
J Neurointerv Surg. 2018 Jul;10(7):625-628. doi: 10.1136/neurintsurg-2017-013398. Epub 2017 Nov 16.
Studies comparing endovascular stroke treatment using mechanical thrombectomy (MT) with or without prior IV tissue plasminogen activator (tPa) have included only 30% of internal carotid artery terminus occlusions (ICA-O), a known predictor of recanalization failure with IV tPa.
To carry out a retrospective multicenter analysis of prospectively collected data of consecutive patients to investigate the impact of intravenous thrombolysis on ICA-O by comparing patients treated with MT alone or bridging therapy (BT).
Patients with ICA-O treated with MT alone or BT were retrospectively examined and compared. Demographic data, vascular risk factors, treatment modalities, complications, technical and clinical outcomes were recorded. A propensity score (PS) analysis was used to compare modified Rankin Scale (mRS) score at 3 months and intracerebral hemorrhage (ICH) between groups.
141 consecutive patients (60% BT/40% MT) were included between January 2014 and June 2016. Baseline characteristics did not differ between the groups. There was no significant difference in the rate of Thrombolysis in Cerebral Infarction 2b/3, distal emboli, and median number of passes between the groups. There was a significant difference between BT and MT groups in the median time between imaging and groin puncture (median 97 min vs 75, p=0.007), the rate of ICH (44% vs 27%, p=0.05), but not for symptomatic ICH (18% vs 13%, p=0.49). With PS, there was a trend towards a higher rate of ICH (OR=2.3, 95% CI 0.9 to 5.9, p=0.09) in the BT group compared with the MT alone group, with no difference in mRS score ≤2 at 3 months (OR=1.6, 95% CI 0.7 to 3.7, p=0.29).
There was no significant difference in clinical outcomes between patients receiving bridging therapy versus direct thrombectomy. Bridging therapy delayed time to groin puncture and increased ICH rate.
比较血管内卒中介入治疗中使用机械血栓切除术(MT)与或不与静脉内组织型纤溶酶原激活剂(tPA)联合应用的研究仅纳入了 30%的颈内动脉终末段闭塞(ICA-O)患者,而静脉内 tPA 治疗失败的已知预测因素就是 ICA-O。
通过比较单独使用 MT 治疗与桥接治疗(BT)的患者,对连续患者前瞻性收集的数据进行回顾性多中心分析,以调查静脉溶栓对 ICA-O 的影响。
回顾性检查并比较了接受单独 MT 或 BT 治疗的 ICA-O 患者。记录人口统计学数据、血管危险因素、治疗方式、并发症、技术和临床结果。使用倾向评分(PS)分析比较组间 3 个月时改良 Rankin 量表(mRS)评分和颅内出血(ICH)。
2014 年 1 月至 2016 年 6 月期间,共纳入 141 例连续患者(60% BT/40% MT)。两组间的基线特征无差异。两组间血栓溶解率 2b/3、远端栓塞和中位数穿通次数无显著差异。BT 组和 MT 组之间在影像到腹股沟穿刺之间的中位数时间(中位数 97 min 与 75,p=0.007)、ICH 发生率(44% 与 27%,p=0.05)存在显著差异,但症状性 ICH 发生率(18% 与 13%,p=0.49)无差异。PS 后,BT 组与 MT 组相比,ICH 发生率呈上升趋势(比值比 2.3,95%CI 0.9 至 5.9,p=0.09),但 3 个月时 mRS 评分≤2 的差异无统计学意义(比值比 1.6,95%CI 0.7 至 3.7,p=0.29)。
接受桥接治疗与直接血栓切除术的患者之间的临床结果无显著差异。桥接治疗延迟了腹股沟穿刺时间,增加了 ICH 发生率。